Report Highlights
The global market for medical imaging should grow from $34.1 billion in 2018 to reach $43.6 billion by 2023 at a compound annual growth rate (CAGR) of 5.1% for the period of 2018-2023.
Report Includes
- 101 data tables and 108 additional tables
- Country specific data and analysis for United States, Canada, Mexico, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Australia, Middle East, Africa and Latin America
- Detailed description of innovative imaging modalities such as mammography and 3D ultrasonic holography
- Identification of research areas for biomedical imaging and applications of biophotonics and biomedical imaging in research
- Comparative study of focused ultrasound with an ideal surgical tool and study challenges that need to be addressed in global medical imaging instruments market to achieve fiscal succes
- Identification of various strategies adopted by market players to enhance their market position, including expansion, product launch, acquisition and merger, innovation, partnership and joint venture
- Company profiles of major players in the market, including Agfa Healthcare, Boston Scientific, Bruker Corp., Canon, Inc. and GE Healthcare
Report Scope
The scope of this report is broad and covers various types of products available in the medical imaging instruments market and potential application sectors across various industries. The medical imaging instruments market is broken down into product types such as X-ray systems, ultrasound devices, MRI, CT and nuclear imaging. Revenue forecasts from 2018 to 2023 are given for each product type, technologies, application and end users with estimated valued derived from the revenue of manufacturers’ total revenues.
The report also includes a discussion of the major players across each regional medical imaging instrument market. It explains the major drivers and regional dynamics of the global medical imaging instruments market and current trends within the industry. An analysis of the regulatory scenario that governs the medical imaging industry is also included in the scope of this report.
The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors in the global medical imaging instruments market.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Advanced Materials for Extreme Environments: Global Markets (AVM198B)
- Rare Disease Diagnostics: Technologies and Global Markets (PHM227B)
- Breakthrough Therapies: Market Dynamics and Investment Opportunities (PHM176B)
- Green Hydrogen: Global Markets (ENV060B)
- Softgel Capsules: Global Markets (PHM244B)
Related Reports
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Operating Room Equipment and Software: Global Markets
The global market for operating room equipment and software reached $26.1 billion in 2022. The market is estimated to increase from $27.8 billion in 2023 to reach $38.9 billion by 2028, at a compound annual growth rate (CAGR) of 6.9% from 2023 through 2028.
Terahertz Radiation Systems: Technologies and Global Markets
The global terahertz (THz) radiation systems market should reach $1.9 billion by 2028 from $795.7 million in 2023 at a compound annual growth rate (CAGR) of 18.9% for the forecast period of 2023 to 2028.
Global Markets for CT Scanners
The global market for CT scanners is estimated to increase from $7.8 billion in 2022 to reach $10.6 billion by 2027, at a compound annual growth rate (CAGR) of 6.5% from 2022 through 2027.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More